Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the therapeutic drug monitoring market grown in recent years?

Recent years have witnessed robust growth in the therapeutic drug monitoring market size. With a compound annual growth rate (CAGR) of 8.9%, the market is estimated to escalate from $2.23 billion in 2024 to $2.43 billion in 2025. The historical growth of this market is largely due to an increase in chronic diseases, concerns about drug safety, the incorporation of pharmacogenomics, an upsurge in drug development, and regulation that emphasizes precision medicine.

How is the therapeutic drug monitoring market size expected to evolve during the forecast period?

The market for therapeutic drug monitoring is projected to experience substantial growth in the years ahead. It’s forecasted to reach “$3.72 billion by 2029, with a compound annual growth rate (CAGR) of 11.3%. The growth expected in the forecast period can be credited to a growing interest in oncology applications, the rise of personalized medicine, a worldwide boom in the elderly population, an increase in point-of-care testing, and a surge in pharmaceutical R&D spending. Key trends expected during the forecast period are personalized medicine, technological innovation, a surge in drug production and consumption, point-of-care testing (POCT), and the introduction of new biomarkers and assay technologies.

Get your therapeutic drug monitoring market report here!

https://www.thebusinessresearchcompany.com/report/therapeutic-drug-monitoring-global-market-report

Which key drivers are propelling the therapeutic drug monitoring market’s growth?

The growth of the therapeutic drug monitoring market is expected to be fuelled by the increasing number of organ transplant surgeries. Organ transplants, which involve transferring an organ from a donor to a recipient, rely heavily on the Therapeutic Drug Monitoring (TDM) of immunosuppressive medicines. This is critical in managing patients undergoing solid organ transplants. Optimizing TDM helps avoid toxicity or dangerously low doses that could lead to organ rejection. An article published in January 2023 by the United Network for Organ Sharing, an organization responsible for overseeing organ transplants in the United States, stated that there were 42,887 organ transplants performed in the country in 2022. This was a 3.7% increase from 2021. Hence, the escalating number of organ transplant surgeries is directly promoting the growth of the therapeutic drug monitoring market.

What are the market segments in the therapeutic drug monitoring industry?

The therapeutic drug monitoring market covered in this report is segmented –

1) By Product: Consumables, Equipment, Immunoassay Analyzers, Chromatography And Detectors

2) By Technology: Immunoassays, Chemiluminescence Immunoassays, Chemiluminescence Immunoassays, Colorimetric Immunoassays, Fluorescence Immunoassays, Radioimmunoassay, Other Immunoassays, Chromatography-Ms, Lc-Ms, Gc-Ms

3) By Class Of Drug: Antiepileptic Drugs, Antibiotic Drugs, Immunosuppressant Drugs, Antiarrhythmic Drugs, Bronchodilator Drugs, Psychoactive Drugs, Other Drugs

4) By End-user: Hospital Laboratories, Commercial and Private Laboratories, Other End Users

Subsegments:

1) By Consumables: Reagents, Test Kits, Sample Collection Containers, Calibration Standards

2) By Equipment: Analyzers, Incubators, Centrifuges, Other Equipment

3) By Immunoassay Analyzers: ELISA Analyzers, Chemiluminescent Immunoassay Analyzers, Radioimmunoassay Analyzers

4) By Chromatography And Detectors: High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), Mass Spectrometry (MS), Other Chromatography Techniques

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10069&type=smp

Which leading companies are shaping the growth of the therapeutic drug monitoring market?

Major companies operating in the therapeutic drug monitoring market include Abbott Laboratories Inc., F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Sekisui Medical Co., Buehlmann Laboratories AG, Danaher Corporation, Bio-Rad Laboratories Inc., bioMérieux SA, Randox Laboratories Limited, Chromsystems Instruments & Chemicals GmbH, Grifols SA, Merck KGaA, BioChem Pharmaceuticals, Beckman Coulter Inc., DiaSorin S.p.A., Hologic Inc., Immunodiagnostic Systems Holdings plc, Kronus Inc., QuidelOrtho Corporation, Sysmex Corporation, TDM Solutions Inc., Theradiag, Tosoh Bioscience LLC, Trinity Biotech plc, Associated Regional and University Pathologists Inc., Mayo Clinic Laboratories, Quest Diagnostics

What key trends are currently impacting the therapeutic drug monitoring market’s development?

Key players in the therapeutic drug monitoring market are concentrating on advances in anti-idiotypic antibody technology to improve assay sensitivity and specificity for accurate measurement of biologic drug levels and patient immune response evaluation. This technology is beneficial in therapeutic drug monitoring as it ensures precise detection and quantification of biologic drug levels, correct dosing, and monitoring of patient immune responses. For example, Bio-Rad Laboratories, a biotechnology company based in the US, in June 2024 introduced new anti-idiotypic and anti-monomethyl auristatin E (MMAE) antibodies for bioanalytical assays that improved pharmacokinetic (PK) and antidrug-antibody (ADA) monitoring. These innovative antibodies improve the dependability of assays for antibody-drug conjugates (ADCs) and play a vital role in the therapeutic drug monitoring market, facilitating accurate drug level and immune response evaluations for effective patient dosage.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10069

Which geographic areas are influencing the growth of the therapeutic drug monitoring market?

North America was the largest region in the therapeutic drug monitoring market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global therapeutic drug monitoring market report during the forecast period. The regions covered in the therapeutic drug monitoring market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Operating Room Equipment Global Market Opportunities And Strategies To 2030: COVID 19 Implications and Growth

https://www.thebusinessresearchcompany.com/report/operating-room-equipment-market

Airway Management Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/airway-management-devices-global-market-report

Veterinary Anesthesia Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-anesthesia-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: